CytoDyn
Most recent annual filing: 2026-08-31
- Leronlimab mCRC interim2026Leronlimab mCRC interim, 2026, material
- mTNBC dose escalation study MDFall of 2026mTNBC dose escalation study MD, Fall of 2026, routine
- CytoDyn financing2027CytoDyn financing, 2027, routine
- GBM pilot study trial startearly 2027GBM pilot study trial start, early 2027, routine
Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.
Pipeline (3 active programs)
Biotech Distilled coverage (5)
- 2026-08-31 UPDATE: CytoDyn (CYDY) - The Going Concern Comes Back 🔒 Paid
- 2026-06-04 UPDATE: CytoDyn (CYDY) - Natera Puts Its Name on the ctDNA Story
- 2026-05-01 UPDATE: CytoDyn (CYDY) - The Tumor Biopsy I Asked For 🔒 Paid
- 2026-04-27 UPDATE: CytoDyn (CYDY) - The Lie Detector Test Beeped Green 🔒 Paid
- 2026-04-21 CytoDyn (CYDY) - Scientific Deep Dive for Leronlimab and Pipeline Products
Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.